HEALTH

Even stronger obesity drug could further upend weight-loss care

Name: Even stronger obesity drug could further upend weight-loss care
Description: FDA approval for use of tirzepatide for chronic weight management could come this year, drugmaker Eli Lilly said.

FDA approval for use of tirzepatide for chronic weight management could come this year, drugmaker Eli Lilly said.

April 27, 2023

FDA approval for use of tirzepatide for chronic weight management could come this year, drugmaker Eli Lilly said.